Novel CFTR modulator, increasing CFTR protein expression across different mutations, including F508del, by increasing CFTR mRNA levels by ~1.5 to ~2-fold in HBE cells

Natural antifungal agent, against postharvest fruit pathogenic fungi

Novel inhibitor of hypoxia-induced VEGF expression

Novel Bovine Viral Diarrhea (BVD) Inhibitor, specifically blocking BVDV cell entry

Na-K ATPase inhibitor, stimulating SERCA2a and accelerating calcium cycling in heart failure by relieving phospholamban inhibition

Novel PSMA ligand conjugated with fluorescent dye SulfoCy7, demonstrating good visualization of PSMA-expressing tumors and the absence of any explicit toxicity up to 87.9 mg/kg

Novel Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection, Visualizing Tumors in Real Time

Novel Selective, competitive GPR55 antagonist

Potent GPR55 antagonist

Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55

Novel Agonist of the Cannabinoid-Activated Orphan G-Protein-Coupled Receptor GPR18, being selective versus the CB-sensitive receptors CB1, CB2, and GPR55

The first potent and selective inhibitor of human nucleoside triphosphate diphosphohydrolase-2 (NTPDase2)

Fluorescent Probe for Ecto-5'--nucleotidase (CD73)

Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 32.1 nM)

Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 27.9 nM)

Fluorescent Probe for Ecto-5'--nucleotidase (CD73)

Novel potent and selective agonist of the orphan G protein-coupled receptor 84 (GPR84)

Novel Potent Agonist of the Orphan G Protein-Coupled Receptor GPR17 (EC 50 12 nM)

Novel Potent and Selective Antagonist for the UTP-Activated P2Y4 Receptor

Novel potent Lp1NTPDase inhibitor

Highly potent, selective, competitive, and reversible inhibitor of monoamine oxidase B (MAO-B)

Novel fluorescent-labeled selective adenosine A2B receptor antagonist

Potent competitive antagonist and positive modulator of the P2X2 receptor

Positive modulator of ATP effects at P2X2 receptors

Potent competitive antagonist and positive modulator of the P2X2 receptor with >100-fold selectivity versus P2X4, P2X7, and several investigated P2Y receptor subtypes (P2Y(2,4,6,12))

Unique inhibitor of bacterial chromosomal partitioning, increasing the efficacy of bortezomib and sorafenib through regulation of stress granule formation

Naturally occurring inhibitor of FOXO1a nuclear export

Highly potent and selective VDR-coactivator inhibitor

Novel inhibitor of upstream IκB kinase (IKK), specifically inhibiting the IκB phosphorylation and degradation and the subsequent nuclear translocation of NF-κB

Novel selective 5-HT6 receptor antagonist, enhancing cognition and memory and potently decreasing food intake and body weight in rodents